Aldeyra Therapeutics, Inc.

ALDX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$59,341$41,241$50,351$54,527
Short-Term Investments$15,957$40,678$39,707$46,624
Receivables$0$0$756$0
Inventory$0$0$0$0
Other Curr. Assets$2,163$2,639$1,915$2,921
Total Curr. Assets$77,460$84,558$92,729$104,072
Property Plant & Equip (Net)$341$405$467$267
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$267
Total NC Assets$341$405$467$534
Other Assets$0$0$0$0
Total Assets$77,801$84,963$93,196$104,607
Liabilities
Payables$13$1,455$346$180
Short-Term Debt$15,471$15,412$255$303
Tax Payable$0$0$0$0
Deferred Revenue$6,000$6,000$6,000$6,000
Other Curr. Liab.$7,013$6,664$7,684$12,118
Total Curr. Liab.$28,484$29,531$14,286$18,602
LT Debt$73$143$15,311$15,000
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$73$143$15,311$15,000
Other Liabilities$0$0$0$0
Cap. Leases$0$407$468$272
Total Liabilities$28,556$29,675$29,597$33,602
Equity
Pref Stock$0$0$0$0
Common Stock$60$60$60$60
Retained Earnings-$477,496-$469,807-$460,040-$450,111
AOCI$1-$11$2$37
Other Equity$526,680$525,046$523,577$521,018
Total Equity$49,245$55,288$63,599$71,005
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$77,801$84,963$93,196$104,607
Net Debt-$43,797-$25,685-$34,784-$39,224